港股详情

本页面由Tiger Fintech (Singapore) Pte. Ltd.提供服务

晶泰控股-P

4.280

-0.220-4.89%

成交量：7,231.88万

成交额：3.12亿

市值：172.06亿

市盈率：-5.03

高：4.510

开：4.510

低：4.210

收：4.500

数据加载中...

总览公司新闻公告

港股异动 | AI医疗概念股早盘走强 AI赋能医药医疗不断取得新进展多家医疗公司表态接入DeepSeek

晶泰(02228.HK)完成对或然生物战略投资推进首创新药研发

阿斯达克财经

异动解读 | AI制药前景看好,晶泰控股-P盘中大涨6.26%

晶泰控股-P盘中异动早盘急速上涨6.77%

晶泰控股－Ｐ(02228)出现大手卖出340万股，成交价$6.28，涉资2.135千万

阿斯达克财经

晶泰科技战略投资或然生物，强强联合加速首创新药开发

医药生物行业跟踪周报：AI医疗仍被显著低估，关注华大智造、晶泰控股-P等

异动解读 | 晶泰控股-P(02228)盘中大涨5.32% 与韩国药企签署合作增加业务订单

晶泰控股-P盘中异动快速上涨5.14%

晶泰控股-P02月05日主力资金流入327万元连续3日加仓

晶泰控股－Ｐ(02228)出现大手卖出96.9万股，成交价$5.64，涉资546.516万

阿斯达克财经

港股概念追踪|高盛将目光投向“AI+医疗” 行业回暖拐点降至（附概念股）

晶泰控股-P现涨逾7% 与韩国药企JW签署千万级人民币战略合作协议

异动解读 | 晶泰控股-P盘中大涨8.55% 携手韩国药企开拓海外市场

晶泰控股－Ｐ(02228)股价上升5.019%，现价港币$5.65

阿斯达克财经

晶泰控股-P现涨逾9% 公司与韩国制药企业JW达成合作

【港股通】晶泰控股(02228)涨10.64% 与韩制药企业JW合作以AI+机器人打造药物合成实验室

异动解读 | 伙韩国JW Pharmaceutical研发新药晶泰控股盘中大涨5.02%

晶泰控股-P(02228)上涨5.02%，报5.23元/股

晶泰控股-P盘中异动早盘股价大涨5.02%

{"basename":"/hans","ssrTDKData":{"titleTemplate":"%s - 老虎证券","title":"老虎证券全球投资理财平台| 一站式投资美股新股港股A股","description":"老虎证券助您一站式投资美股，新股，港股，A股等全球金融理财产品。新加坡华人最信赖的在线投资平台，现在加入即享低费用，24/5 无时差炒美股投资理财！","keywords":"老虎证券,老虎证券开户,老虎券商,老虎证券官网,老虎证券app,tigertrade老虎证券,股票,炒股,新加坡股票交易平台,投资,投资理财","social":{"ogDescription":"老虎证券助您一站式投资美股，新股，港股，A股等全球金融理财产品。新加坡华人最信赖的在线投资平台，现在加入即享低费用，24/5 无时差炒美股投资理财！","ogImage":"https://c1.itigergrowtha.com/portal5/static/media/og-logo.be62fbe1.png","ogUrl":"https://www.itiger.com/hans/stock/02228/news?page=10"},"companyName":"老虎证券"},"pageData":{"isMobile":false,"isTiger":false,"isTTM":true,"region":"SGP","license":"TBSG","edition":"fundamental","symbol":"02228","isAnalysisPage":false},"__swrFallback__":{"@#url:\"https://hq.skytigris.cn/stock_info/detail/global\",params:#delay:false,,method:\"POST\",data:#items:@#symbol:\"02228\",,,,,undefined,":{"symbol":"02228","market":"HK","secType":"STK","nameCN":"晶泰控股-P","latestPrice":4.28,"timestamp":1747296514029,"preClose":4.5,"halted":0,"volume":72318770,"delay":0,"floatShares":4020000000,"shares":4020000000,"eps":-0.8513498553110407,"marketStatus":"已收盘","change":-0.22,"latestTime":"05-15 16:08:34","open":4.51,"high":4.51,"low":4.21,"amount":312372052,"amplitude":0.066667,"askPrice":4.28,"askSize":18000,"bidPrice":4.27,"bidSize":107000,"shortable":3,"etf":0,"ttmEps":-0.8556410576787918,"tradingStatus":0,"nextMarketStatus":{"tag":"开盘","tradingStatus":2,"beginTime":1747359000000},"marketStatusCode":5,"adr":0,"listingDate":1718208000000,"exchange":"SEHK","adjPreClose":4.5,"openAndCloseTimeList":[[1747272600000,1747281600000],[1747285200000,1747296000000]],"volumeRatio":1.257145,"lotSize":1000,"spreadScale":0,"tradeCurrency":"HKD"},"@#url:\"https://hq.skytigris.cn/stock_info/fundamental/all\",params:#delay:false,,method:\"POST\",data:#items:@#symbol:\"02228\",,,,,undefined,":{"symbol":"02228","floatShares":4020000000,"roa":"-10.69%","roe":"--","lyrEps":-0.85135,"volumeRatio":1.257145,"shares":4020000000,"dividePrice":0,"high":4.51,"amplitude":0.066667,"preClose":4.5,"low":4.21,"week52Low":3.05,"pbRate":"4.01","psRate":"59.62","week52High":16.2,"institutionHeld":0,"latestPrice":4.28,"committee":0.712,"eps":-0.8513498553110407,"divideRate":0,"volume":72318770,"delay":0,"ttmEps":-0.8556410576787918,"open":4.51,"prevYearClose":5.98,"prevWeekClose":4.63,"prevMonthClose":5.16,"prevQuarterClose":5.89,"fiveDayClose":4.7,"twentyDayClose":4.65,"sixtyDayClose":6.05},"$inf$@#url:\"https://stock-news.skytigris.cn/v2/news/list\",params:#symbols:\"02228\",pageSize:20,pageCount:10,lang_content:\"cn\",edition:\"fundamental\",,,undefined,":[{"items":[{"id":"2510006497","title":"港股异动 | AI医疗概念股早盘走强 AI赋能医药医疗不断取得新进展 多家医疗公司表态接入DeepSeek","url":"https://stock-news.laohu8.com/highlight/detail?id=2510006497","media":"智通财经","labels":["corporation","movement"],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2510006497?lang=zh_cn&edition=fundamental","pubTime":"2025-02-10 11:31","pubTimestamp":1739158274,"startTime":"0","endTime":"0","summary":"木头姐强调称，医疗保健是最被低估的AI应用。国金证券认为，随着人工智能技术的发展与进步，AI在赋能医药医疗、推动行业升级方面不断取得新进展，人工智能在医药健康领域的应用有望进入加速发展阶段。此外，多家医疗公司近期相继表态接入deepseek。企业有望借助AI进一步提高产品竞争力和客户粘性，巩固行业地位和竞争优势。此外，用好Deepseek等AI工具有助于企业降本增效、改善盈利水平。","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":["earning"],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"http://www.zhitongcaijing.com/content/detail/1247612.html","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"corporation,movement","news_rank":0,"length":0,"strategy_id":0,"source":"stock_zhitongcaijing","symbols":["02252","09955","159891","02228","159938","02158","02192","09939"],"gpt_icon":0},{"id":"2510003387","title":"晶泰(02228.HK)完成对或然生物战略投资 推进首创新药研发","url":"https://stock-news.laohu8.com/highlight/detail?id=2510003387","media":"阿斯达克财经","labels":["corporation"],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2510003387?lang=zh_cn&edition=fundamental","pubTime":"2025-02-10 10:33","pubTimestamp":1739154780,"startTime":"0","endTime":"0","summary":"晶泰控股-P公布，完成对或然生物的战略投资，并建立深度研发合作。双方正基于或然生物在全球未满足的临床需求领域所发现的First-in-Class靶点，共同推进创新药物研发。或然生物联合创始人、首席运营官杨彬表示，期待在AI新药研发平台赋能下加快速度，开发出更多高特异性、低毒副作用和具有巨大临床价值的小分子抑制剂，将优质高效的药物尽早带给全球患者。晶泰现报6.47元，升9.48%，成交1.32亿股，涉资8.53亿元。沽空资料截至 2025-02-07 16:25。","market":"fut","thumbnail":"https://plib.aastocks.com/aafnnews/image/medialib/20240611135659493_s.jpg","type":0,"news_type":0,"thumbnails":["https://plib.aastocks.com/aafnnews/image/medialib/20240611135659493_s.jpg"],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"http://www.aastocks.com/tc/stocks/news/aafn-con/NOW.1415905/latest-news/AAFN","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"corporation","news_rank":0,"length":0,"strategy_id":0,"source":"aastocks_highlight","symbols":["159992","BK1141","06978","02228","BK1574","BK1161"],"gpt_icon":0},{"id":"1112152431","title":"异动解读 | AI制药前景看好,晶泰控股-P盘中大涨6.26%","url":"https://stock-news.laohu8.com/highlight/detail?id=1112152431","media":"异动解读","labels":["movement"],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/1112152431?lang=zh_cn&edition=fundamental","pubTime":"2025-02-10 09:30","pubTimestamp":1739151023,"startTime":"0","endTime":"0","summary":"2月10日,晶泰控股-P(02228)股价盘中大涨6.26%,引起市场关注。\n\n对于这次晶泰控股-P股价上涨,投资者普遍认为,与公司在人工智能(AI)制药领域的布局前景较好有关。近日,东吴证券发布医药生物行业研报指出,随着生成式AI与传统AI结合,AI医疗技术将为疾病诊断、风险预测和个性化治疗方案提供新动能,给制药行业带来创新机遇。报告建议重点关注晶泰控股-P等一批AI制药龙头企业。\n\n业内人士分析认为,晶泰控股-P致力于利用AI技术促进新药研发,在AI辅助药物发现、临床前评估等领域已取得一定成绩。未来,随着AI医疗不断发展,公司有望进一步受益。","market":"us","thumbnail":"","type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":"","theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":"异动解读 | AI制药前景看好,晶泰控股-P盘中大涨6.26%","news_tag":"movement","news_rank":0,"length":0,"strategy_id":0,"source":"ai_movement_cn","symbols":["02228"],"gpt_icon":0},{"id":"2510072736","title":"晶泰控股-P盘中异动 早盘急速上涨6.77%","url":"https://stock-news.laohu8.com/highlight/detail?id=2510072736","media":"市场透视","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2510072736?lang=zh_cn&edition=fundamental","pubTime":"2025-02-10 09:30","pubTimestamp":1739151006,"startTime":"0","endTime":"0","summary":"2025年02月10日早盘09时30分，晶泰控股-P股票出现异动，股价快速上涨6.77%。晶泰控股-P股票所在的生物技术行业中，整体跌幅为0.29%。其相关个股中，晶泰控股-P、科济药业-B、来凯医药-B涨幅较大，振幅较大的相关个股有和铂医药-B、晶泰控股-P、科济药业-B，振幅分别为1.93%、1.52%、1.07%。晶泰控股-P公司简介：晶泰控股有限公司是一家主要从事为制药及材料科学等产业提供药物及材料科学研发解决方案及服务的控股公司。","market":"hk","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tencent","url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20250210093006987fc0f1&s=b","rn_cache_url":null,"customStyle":"body{padding-top:10px;}#news_title{font-weight:bold;#titleStyle#;}#news_description span{font-size:12px;#descriptionStyle#;}.footer-note{#statement#}","selectors":".mod-LoadTzbdNews, body","filters":".relate-stock, .hot-list, .recom-box, .wx-sou","directOrigin":true},"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20250210093006987fc0f1&s=b","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"tencent","symbols":["02228","BK1141"],"gpt_icon":0},{"id":"2510072103","title":"晶泰控股－Ｐ(02228)出现大手卖出340万股，成交价$6.28，涉资2.135千万","url":"https://stock-news.laohu8.com/highlight/detail?id=2510072103","media":"阿斯达克财经","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2510072103?lang=zh_cn&edition=fundamental","pubTime":"2025-02-10 09:20","pubTimestamp":1739150400,"startTime":"0","endTime":"0","summary":"[大手成交]晶泰控股－Ｐ(02228)在上午09:20出现大手卖出，成交量为340万，成交价为港币$6.28，涉资2.135千万。至目前为止，股价升6.261%，今日最高价为$6.28，而最低价为$6.28，总成交量为340万股，总成交金额港币$2.135千万。","market":"hk","thumbnail":"https://plib.aastocks.com/aafnnews/image/medialib/20180126132514810_s.jpg","type":0,"news_type":0,"thumbnails":["https://plib.aastocks.com/aafnnews/image/medialib/20180126132514810_s.jpg"],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"http://www.aastocks.com/tc/stocks/news/aamm-content/AAT25021045/aamm-all-category","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"-1","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"aastocks_highlight","symbols":["BK1141","02228"],"gpt_icon":0},{"id":"2510507284","title":"晶泰科技战略投资或然生物，强强联合加速首创新药开发","url":"https://stock-news.laohu8.com/highlight/detail?id=2510507284","media":"美通社","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2510507284?lang=zh_cn&edition=fundamental","pubTime":"2025-02-10 09:02","pubTimestamp":1739149320,"startTime":"0","endTime":"0","summary":"此次获得晶泰科技的战略投资和技术合作，将进一步加速或然生物的管线开发。晶泰科技的一站式药物研发平台已经成功助力国内外多家大型药企与创新生物科技公司快速取得管线突破，此次强强联合，将为或然生物开发高价值的药物管线注入强劲的创新驱动力。或然生物旨在蛋白翻译调控领域挖掘潜在靶标，以治疗最具挑战性的疾病，而晶泰科技在挑战全新靶点上具备独到的AI技术优势，双方的密切合作将会大大加速First-in-Class药物靶点和管线研发进程。","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://wwwold.prnasia.com/story/archive/4615194_ZH15194_1","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"prnasia","symbols":["02228","BK1141"],"gpt_icon":0},{"id":"2510304192","title":"医药生物行业跟踪周报：AI医疗仍被显著低估，关注华大智造、晶泰控股-P等","url":"https://stock-news.laohu8.com/highlight/detail?id=2510304192","media":"东吴证券","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2510304192?lang=zh_cn&edition=fundamental","pubTime":"2025-02-09 22:07","pubTimestamp":1739110039,"startTime":"0","endTime":"0","summary":"关注AI医疗投资机会。具体思路：1）从成长性角度选股，主要集中在AI医疗、创新药领域，建议关注润达医疗、晶泰控股-P、百利天恒、百济神州、益方生物、迪哲医药、海思科等；科伦博泰、信达生物、三生制药、歌礼制药等。","market":"hk","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tencent","url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20250209220724987f68c3&s=b","rn_cache_url":null,"customStyle":"body{padding-top:10px;}#news_title{font-weight:bold;#titleStyle#;}#news_description span{font-size:12px;#descriptionStyle#;}.footer-note{#statement#}","selectors":".mod-LoadTzbdNews, body","filters":".relate-stock, .hot-list, .recom-box, .wx-sou","directOrigin":true},"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20250209220724987f68c3&s=b","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"tencent","symbols":["02228","688114","BK1141"],"gpt_icon":0},{"id":"1121971947","title":"异动解读 | 晶泰控股-P(02228)盘中大涨5.32% 与韩国药企签署合作增加业务订单","url":"https://stock-news.laohu8.com/highlight/detail?id=1121971947","media":"异动解读","labels":["movement"],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/1121971947?lang=zh_cn&edition=fundamental","pubTime":"2025-02-06 09:48","pubTimestamp":1738806531,"startTime":"0","endTime":"0","summary":"$晶泰控股-P$今日盘中涨幅一度扩大至5.32%,引起了市场的广泛关注。这无疑为晶泰科技增加了宝贵的海外药企客户订单,标志着其实验室自动化解决方案在海外市场进一步拓展,有助于提高公司的营收和利润。另一方面,晶泰科技上月才完成了一次大规模的配股融资,成功募集超过11.3亿港元资金,金额更是超过其首次公开募股时的募资规模。","market":"hk","thumbnail":"","type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":"","theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"movement","news_rank":0,"length":0,"strategy_id":0,"source":"ai_movement_cn","symbols":["02228"],"gpt_icon":0},{"id":"2509260383","title":"晶泰控股-P盘中异动 快速上涨5.14%","url":"https://stock-news.laohu8.com/highlight/detail?id=2509260383","media":"市场透视","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2509260383?lang=zh_cn&edition=fundamental","pubTime":"2025-02-06 09:31","pubTimestamp":1738805512,"startTime":"0","endTime":"0","summary":"2025年02月06日早盘09时31分，晶泰控股-P股票出现波动，股价急速拉升5.14%。截至发稿，该股报5.930港元/股，成交量966.7万股，换手率0.26%，振幅4.61%。晶泰控股-P股票所在的生物技术行业中，整体涨幅为0.23%。其相关个股中，晶泰控股-P、再鼎医药、奥星生命科技涨幅较大，振幅较大的相关个股有晶泰控股-P、乐普生物-B、亚盛医药-B，振幅分别为4.26%、3.75%、2.34%。","market":"hk","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tencent","url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20250206093152abc408b3&s=b","rn_cache_url":null,"customStyle":"body{padding-top:10px;}#news_title{font-weight:bold;#titleStyle#;}#news_description span{font-size:12px;#descriptionStyle#;}.footer-note{#statement#}","selectors":".mod-LoadTzbdNews, body","filters":".relate-stock, .hot-list, .recom-box, .wx-sou","directOrigin":true},"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20250206093152abc408b3&s=b","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"tencent","symbols":["BK1141","02228"],"gpt_icon":0},{"id":"2509479497","title":"晶泰控股-P02月05日主力资金流入327万元 连续3日加仓","url":"https://stock-news.laohu8.com/highlight/detail?id=2509479497","media":"市场透视","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2509479497?lang=zh_cn&edition=fundamental","pubTime":"2025-02-05 16:17","pubTimestamp":1738743425,"startTime":"0","endTime":"0","summary":"02月05日, 晶泰控股-P股价涨4.83%，报收5.64元，成交金额9.96亿元，换手率4.78%，振幅15.43%，量比2.83。晶泰控股-P今日主力资金净流入327万元，连续3日净流入，上一交易日主力净流入695万元。近一年数据显示，该股主力连续3日净流入后，次日上涨概率为62.50%，平均涨幅为7.10%。该股近5个交易日上涨14.23%，主力资金累计净流出1670万元，其中1个交易日为股价下跌时净流入；近20日主力资金累计净流入3101万元，其中净流入天数为9日。","market":"hk","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tencent","url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20250205161747abc314be&s=b","rn_cache_url":null,"customStyle":"body{padding-top:10px;}#news_title{font-weight:bold;#titleStyle#;}#news_description span{font-size:12px;#descriptionStyle#;}.footer-note{#statement#}","selectors":".mod-LoadTzbdNews, body","filters":".relate-stock, .hot-list, .recom-box, .wx-sou","directOrigin":true},"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20250205161747abc314be&s=b","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"tencent","symbols":["BK1141","02228"],"gpt_icon":0},{"id":"2509408053","title":"晶泰控股－Ｐ(02228)出现大手卖出96.9万股，成交价$5.64，涉资546.516万","url":"https://stock-news.laohu8.com/highlight/detail?id=2509408053","media":"阿斯达克财经","labels":["shareholding"],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2509408053?lang=zh_cn&edition=fundamental","pubTime":"2025-02-05 16:08","pubTimestamp":1738742880,"startTime":"0","endTime":"0","summary":"[大手成交]晶泰控股－Ｐ(02228)在下午04:08出现大手卖出，成交量为96.9万，成交价为港币$5.64，涉资546.516万。至目前为止，股价升4.833%，今日最高价为$5.98，而最低价为$5.15，总成交量为1.759亿股，总成交金额港币$9.957亿。","market":"fut","thumbnail":"https://plib.aastocks.com/aafnnews/image/medialib/20180815142908927_s.jpg","type":0,"news_type":0,"thumbnails":["https://plib.aastocks.com/aafnnews/image/medialib/20180815142908927_s.jpg"],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"http://www.aastocks.com/tc/stocks/news/aamm-content/AAV2502056534/aamm-all-category","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"-1","news_top_title":null,"news_tag":"shareholding","news_rank":0,"length":0,"strategy_id":0,"source":"aastocks_highlight","symbols":["02228","BK1141"],"gpt_icon":0},{"id":"2509218674","title":"港股概念追踪|高盛将目光投向“AI+医疗”  行业回暖拐点降至（附概念股）","url":"https://stock-news.laohu8.com/highlight/detail?id=2509218674","media":"智通财经","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2509218674?lang=zh_cn&edition=fundamental","pubTime":"2025-02-05 14:05","pubTimestamp":1738735540,"startTime":"0","endTime":"0","summary":"中信建投表示，近期多项创新器械陆续获批，商保有望为创新产品放量打开新空间，国内AI医疗发展迅速、海外和国内脑机接口技术进展有望持续催化。信达证券发布研报称，2024年医药生物行业在高基数、医疗反腐、DRGS改革、集采降价等因素影响下，行业整体增长承压。展望2025年，商保及AI医疗或助行业转暖，行业拐点将至。AI医疗智能大脑YiduCore赋能全场景解决方案落地。晶泰科技宣布与韩国药企JW Pharmaceutical签署千万级人民币的战略合作协议。","market":"hk","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"http://www.zhitongcaijing.com/content/detail/1245880.html","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"stock_zhitongcaijing","symbols":["BK4588","LU2237443465.HKD","LU2237443382.USD","BK1518","LU0106831901.USD","02506","LU2237443895.HKD","LU2237438978.USD","IE00B19Z3581.USD","YANG","BK4585","BK1141","BK4504","159891","LU1668664300.SGD","IE00BFXG1179.USD","02158","BK4552","BK4516","BK1189","IE0004086264.USD","LU1791807156.HKD","LU2237443622.USD","LU2237443978.SGD","LU2237443549.SGD","02228","HSCEI","BK4533","IE0002270589.USD","IE0004091025.USD","BK4550","IE00BSNM7G36.USD","HSTECH","IE0034235188.USD","IE00B19Z3B42.SGD","BK4127"],"gpt_icon":1},{"id":"2509700441","title":"晶泰控股-P现涨逾7% 与韩国药企JW签署千万级人民币战略合作协议","url":"https://stock-news.laohu8.com/highlight/detail?id=2509700441","media":"新浪港股","labels":["corporation"],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2509700441?lang=zh_cn&edition=fundamental","pubTime":"2025-02-05 11:05","pubTimestamp":1738724700,"startTime":"0","endTime":"0","summary":"　　晶泰控股-P早盘再走高，该股昨日收涨逾8%。截至发稿，股价上涨6.69%，现报5.74港元，成交额3.97亿港元。　　消息面上，晶泰科技昨日宣布与亚洲领先的韩国药企JW Pharmaceutical签署千万级人民币的战略合作协议。晶泰科技将为 JW 提供一套药物发现自动化工作站和基于人工智能的化学反应优化平台，以全面赋能JW的药物研发效率、重复性与成功率。此次与JW的合作，标志着晶泰科技自动化实验室解决方案首次获得海外药企客户的采购，具有重要的里程碑意义。","market":"fut","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://finance.sina.com.cn/stock/hkstock/marketalerts/2025-02-05/doc-ineikxsm5402701.shtml","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"corporation","news_rank":0,"length":0,"strategy_id":0,"source":"sina","symbols":["02228","BK1141"],"gpt_icon":0},{"id":"1159855593","title":"异动解读 | 晶泰控股-P盘中大涨8.55% 携手韩国药企开拓海外市场","url":"https://stock-news.laohu8.com/highlight/detail?id=1159855593","media":"异动解读","labels":["movement"],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/1159855593?lang=zh_cn&edition=fundamental","pubTime":"2025-02-05 10:54","pubTimestamp":1738724096,"startTime":"0","endTime":"0","summary":"晶泰控股-P(02228)今日盘中大涨8.55%,引起了市场的广泛关注。\n\n消息面上,晶泰科技昨日宣布与亚洲领先的韩国药企JW Pharmaceutical签署千万级人民币的战略合作协议。根据协议,晶泰科技将为JW部署一系列高通量自动化合成工站、AI反应条件优化系统及智能分析平台,以满足JW在自动化药物候选分子筛选、合成与工艺优化方向的复杂研发需求。\n\n这一合作标志着晶泰科技自动化实验室解决方案首次获得海外药企客户的采购,具有重要的里程碑意义。市场认为,此举有助于晶泰科技开拓海外市场,增强了公司业务增长前景的信心,推动股价上涨。","market":"us","thumbnail":"","type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":"","theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"movement","news_rank":0,"length":0,"strategy_id":0,"source":"ai_movement_cn","symbols":["02228"],"gpt_icon":0},{"id":"2509096446","title":"晶泰控股－Ｐ(02228)股价上升5.019%，现价港币$5.65","url":"https://stock-news.laohu8.com/highlight/detail?id=2509096446","media":"阿斯达克财经","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2509096446?lang=zh_cn&edition=fundamental","pubTime":"2025-02-05 10:25","pubTimestamp":1738722300,"startTime":"0","endTime":"0","summary":"[上升股]晶泰控股－Ｐ(02228) 股价在上午10:25比前收市价上升5.019%，现股价为港币$5.65。至目前为止，今日最高价为$5.65，而最低价为$5.15。总成交量为3.454千万股，总成交金额为港币$1.849亿。","market":"other","thumbnail":"https://plib.aastocks.com/aafnnews/image/medialib/20180416150419953_s.png","type":0,"news_type":0,"thumbnails":["https://plib.aastocks.com/aafnnews/image/medialib/20180416150419953_s.png"],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"http://www.aastocks.com/tc/stocks/news/aamm-content/AAR2502051966/aamm-all-category","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"aastocks_highlight","symbols":["BK1141","02228"],"gpt_icon":0},{"id":"2508109101","title":"晶泰控股-P现涨逾9% 公司与韩国制药企业JW达成合作","url":"https://stock-news.laohu8.com/highlight/detail?id=2508109101","media":"新浪港股","labels":["corporation"],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2508109101?lang=zh_cn&edition=fundamental","pubTime":"2025-02-04 11:01","pubTimestamp":1738638060,"startTime":"0","endTime":"0","summary":"　　晶泰控股-P早盘一度涨超12%，截至发稿，股价上涨8.64%，报5.41港元，成交额1.13亿港元。　　消息面上，晶泰科技今日宣布，与亚洲领先的韩国药企JW Pharmaceutical签署千万级人民币的战略合作协议。晶泰科技将为JW提供一套药物发现自动化工作站和基于人工智能的化学反应优化平台，以全面赋能JW的药物研发效率、重复性与成功率。此次与JW的合作，标志着晶泰科技自动化实验室解决方案首次获得海外药企客户的采购，具有重要的里程碑意义。","market":"fut","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://finance.sina.com.cn/stock/hkstock/marketalerts/2025-02-04/doc-ineihuth3950976.shtml","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"corporation","news_rank":0,"length":0,"strategy_id":0,"source":"sina","symbols":["BK1574","02228","01477","BK1141","BK1191"],"gpt_icon":0},{"id":"2508109979","title":"【港股通】晶泰控股(02228)涨10.64% 与韩制药企业JW合作 以AI+机器人打造药物合成实验室","url":"https://stock-news.laohu8.com/highlight/detail?id=2508109979","media":"金吾财讯","labels":["corporation"],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2508109979?lang=zh_cn&edition=fundamental","pubTime":"2025-02-04 10:39","pubTimestamp":1738636769,"startTime":"0","endTime":"0","summary":"金吾财讯 | 晶泰控股(02228)股价发力，截至发稿，涨10.64%，报5.5港元，成交额9121万港元。消息面上，晶泰科技宣布，与亚洲领先的韩国药企JW Pharmaceutical签署千万级人民币的战略合作协议。晶泰科技将为JW提供一套药物发现自动化工作站和基于人工智能（AI）的化学反应优化平台，以全面赋能JW的药物研发效率、重复性与成功率。据悉，晶泰科技将为JW部署一系列高通量自动化合成工站、AI反应条件优化系统及智能分析平台，以满足JW在自动化药物候选分子筛选、合成与工艺优化方向的复杂研发需求。","market":"fut","thumbnail":"https://static.szfiu.com/news/20241108/MGQ5MWNhYjgxMjA0ZDU3OGI4Y2EzYTk1OWIyNGM1NTg2NTUyNjEzMTk5Ng==.jpg","type":0,"news_type":0,"thumbnails":["https://static.szfiu.com/news/20241108/MGQ5MWNhYjgxMjA0ZDU3OGI4Y2EzYTk1OWIyNGM1NTg2NTUyNjEzMTk5Ng==.jpg"],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"1952435","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"corporation","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["BK1141","YANG","HSCEI","BK1574","BK1191","HSTECH","02228","01477","07226"],"gpt_icon":0},{"id":"1101858094","title":"异动解读 | 伙韩国JW Pharmaceutical研发新药 晶泰控股盘中大涨5.02%","url":"https://stock-news.laohu8.com/highlight/detail?id=1101858094","media":"异动解读","labels":["movement"],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/1101858094?lang=zh_cn&edition=fundamental","pubTime":"2025-02-04 09:56","pubTimestamp":1738634200,"startTime":"0","endTime":"0","summary":"晶泰控股今日盘中大涨5.02%,股价表现亮眼。据了解,公司与韩国知名药企JW Pharmaceutical签署战略合作协议,共同打造一系列自动化实验室和人工智能系统,推动新一代药物发现。双方希望以AI驱动药物发现,提高研发效率。晶泰控股表示,公司自动化实验室解决方案此前已获复旦大学、中石化等标杆客户采购,但JW成为首个采购的海外药企客户。此次合作有望带动晶泰控股在生物医药领域业务进一步增长,公司前景值得市场期待。","market":"hk","thumbnail":"","type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":"","theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":"异动解读 | 伙韩国JW Pharmaceutical研发新药 晶泰控股盘中大涨5.02%","news_tag":"movement","news_rank":0,"length":0,"strategy_id":0,"source":"ai_movement_cn","symbols":["02228"],"gpt_icon":0},{"id":"2508105978","title":"晶泰控股-P(02228)上涨5.02%，报5.23元/股","url":"https://stock-news.laohu8.com/highlight/detail?id=2508105978","media":"金融界","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2508105978?lang=zh_cn&edition=fundamental","pubTime":"2025-02-04 09:54","pubTimestamp":1738634086,"startTime":"0","endTime":"0","summary":"2月4日，晶泰控股-P(02228)盘中上涨5.02%，截至09:54，报5.23元/股，成交2112.67万元。晶泰控股有限公司主要以量子物理、人工智能和机器人技术为基础，为全球制药、材料科学等领域提供研发解决方案及服务。公司运用量子物理原理、先进的AI技术、高性能云计算以及可扩展和标准化的机器人自动化等技术，服务于农业技术、能源、新型化学品以及化妆品等行业。截至2024年中报，晶泰控股-P营业总收入1.03亿元、净利润-12.37亿元。","market":"us","thumbnail":"","type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://finance.jrj.com.cn/2025/02/04095447943686.shtml","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"jinrongjie_stock","symbols":["BK1141","02228"],"gpt_icon":0},{"id":"2508105294","title":"晶泰控股-P盘中异动 早盘股价大涨5.02%","url":"https://stock-news.laohu8.com/highlight/detail?id=2508105294","media":"市场透视","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2508105294?lang=zh_cn&edition=fundamental","pubTime":"2025-02-04 09:54","pubTimestamp":1738634079,"startTime":"0","endTime":"0","summary":"2025年02月04日早盘09时54分，晶泰控股-P股票出现异动，股价急速上涨5.02%。截至发稿，该股报5.230港元/股，成交量411.9万股，换手率0.11%，振幅4.42%。晶泰控股-P股票所在的生物技术行业中，整体跌幅为0.07%。其相关个股中，北海康成-B、晶泰控股-P、复宏汉霖涨幅较大，振幅较大的相关个股有北海康成-B、亚盛医药-B、复宏汉霖，振幅分别为18.98%、5.18%、5.06%。","market":"hk","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tencent","url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20250204095439a23890a0&s=b","rn_cache_url":null,"customStyle":"body{padding-top:10px;}#news_title{font-weight:bold;#titleStyle#;}#news_description span{font-size:12px;#descriptionStyle#;}.footer-note{#statement#}","selectors":".mod-LoadTzbdNews, body","filters":".relate-stock, .hot-list, .recom-box, .wx-sou","directOrigin":true},"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20250204095439a23890a0&s=b","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"tencent","symbols":["BK1141","02228"],"gpt_icon":0}],"pageSize":20,"totalPage":10,"pageCount":10,"totalSize":200,"code":"91000000","status":"200"}],"@#url:\"https://hq.skytigris.cn/fundamental/corporate_actions/details/02228\",params:#limit:5,,,undefined,":[{"date":"2025-03-28","symbol":"02228","type":"earning","reportTimeType":"","market":"HK","fiscalQuarterEnding":null,"expectedEps":null,"defaultRemindTime":1743125400000,"name":null,"time":"","dateTimestamp":1743091200000,"actualEps":null},{"date":"2024-08-28","symbol":"02228","type":"earning","reportTimeType":"","market":"HK","fiscalQuarterEnding":null,"expectedEps":null,"defaultRemindTime":1724808600000,"name":null,"time":"","dateTimestamp":1724774400000,"actualEps":null}],"@#url:\"https://hq.skytigris.cn/fundamental/dividend/history\",params:#symbol:\"02228\",market:\"HK\",,,undefined,":[],"@#url:\"https://hq.skytigris.cn/fundamental/estimate/recommendation\",params:#symbol:\"02228\",market:\"HK\",delay:false,,,undefined,":{"strongBuy":0.3333,"buy":0.6667,"hold":0,"sell":0,"strongSell":0,"meanLabel":"BUY","meanPercent":0.6667,"analysts":3,"updateTime":1742313600000},"@#url:\"https://hq.skytigris.cn/hkstock/value_analysis/stock/02228\",params:#withQuantilePoint:true,period:\"5year\",factor:\"peRate\",delay:false,algorithm:1,,,undefined,":{"brief":{"id":"02228","date":"2025-05-14","current":-8.240535,"percent":0.674107,"low":-19.121462,"twenty":-11.321925,"median":-8.892407,"eighty":-6.807272,"high":-4.071689,"avg":-9.331711,"sd":2.959567,"marketCap":18089152924},"quantilePoints":[{"date":"2024-06-14","current":-8.922014,"twenty":-9.439723,"median":-9.245582,"eighty":-9.051441,"marketCap":18396572909},{"date":"2024-06-21","current":-8.857946,"twenty":-8.9092,"median":-8.775161,"eighty":-8.737522,"marketCap":18226234271},{"date":"2024-06-28","current":-8.745676,"twenty":-8.918198,"median":-8.816527,"eighty":-8.750223,"marketCap":17987760178},{"date":"2024-07-05","current":-8.747576,"twenty":-8.902934,"median":-8.771787,"eighty":-8.744343,"marketCap":17987760178},{"date":"2024-07-12","current":-9.049063,"twenty":-8.902934,"median":-8.775161,"eighty":-8.741587,"marketCap":18635047002},{"date":"2024-07-19","current":-9.247407,"twenty":-9.172529,"median":-8.857489,"eighty":-8.744343,"marketCap":19043859733},{"date":"2024-07-26","current":-9.575773,"twenty":-9.510189,"median":-8.892407,"eighty":-8.745676,"marketCap":19793349741},{"date":"2024-08-02","current":-9.235042,"twenty":-9.509847,"median":-8.912474,"eighty":-8.745676,"marketCap":19077927461},{"date":"2024-08-09","current":-9.468775,"twenty":-9.510189,"median":-8.974725,"eighty":-8.747576,"marketCap":19691146558},{"date":"2024-08-16","current":-10.464009,"twenty":-9.56947,"median":-9.142341,"eighty":-8.760904,"marketCap":21769277942},{"date":"2024-08-23","current":-10.517808,"twenty":-9.632925,"median":-9.235042,"eighty":-8.768412,"marketCap":21973684308},{"date":"2024-08-30","current":-10.371399,"twenty":-10.303269,"median":-9.325095,"eighty":-8.775161,"marketCap":28923500740},{"date":"2024-09-06","current":-18.461728,"twenty":-10.496901,"median":-9.468775,"eighty":-8.776023,"marketCap":51510404146},{"date":"2024-09-13","current":-17.236995,"twenty":-10.891661,"median":-9.521964,"eighty":-8.857032,"marketCap":47967360474},{"date":"2024-09-20","current":-16.063353,"twenty":-11.51195,"median":-9.559061,"eighty":-8.857763,"marketCap":44969400445},{"date":"2024-09-27","current":-15.483466,"twenty":-14.686278,"median":-9.575773,"eighty":-8.860072,"marketCap":43606691340},{"date":"2024-10-04","current":-13.755671,"twenty":-14.947547,"median":-9.615329,"eighty":-8.879685,"marketCap":38564667654},{"date":"2024-10-10","current":-12.348216,"twenty":-14.780027,"median":-9.846626,"eighty":-8.896618,"marketCap":34408404886},{"date":"2024-10-18","current":-11.446606,"twenty":-14.586898,"median":-10.272952,"eighty":-8.910566,"marketCap":31717054404},{"date":"2024-10-25","current":-12.086709,"twenty":-14.247622,"median":-10.371399,"eighty":-8.935918,"marketCap":33488576240},{"date":"2024-11-01","current":-11.046421,"twenty":-13.547793,"median":-10.507354,"eighty":-8.963954,"marketCap":30626887121},{"date":"2024-11-08","current":-8.233542,"twenty":-13.084166,"median":-10.464009,"eighty":-8.959678,"marketCap":22655038860},{"date":"2024-11-15","current":-6.674421,"twenty":-12.818197,"median":-10.331022,"eighty":-8.873325,"marketCap":18226234271},{"date":"2024-11-22","current":-5.092957,"twenty":-12.605094,"median":-9.956054,"eighty":-8.775506,"marketCap":13899632864},{"date":"2024-11-29","current":-4.071689,"twenty":-12.362191,"median":-9.633447,"eighty":-8.746436,"marketCap":11106079200},{"date":"2024-12-06","current":-6.234627,"twenty":-12.309524,"median":-9.607633,"eighty":-8.729287,"marketCap":16965728349},{"date":"2024-12-13","current":-4.937116,"twenty":-12.241743,"median":-9.572622,"eighty":-8.309283,"marketCap":13422684678},{"date":"2024-12-20","current":-6.992956,"twenty":-12.176011,"median":-9.548971,"eighty":-7.374004,"marketCap":18907588823},{"date":"2024-12-27","current":-7.61626,"twenty":-12.099333,"median":-9.521964,"eighty":-6.992956,"marketCap":20576907476},{"date":"2025-01-03","current":-6.613619,"twenty":-12.089234,"median":-9.489311,"eighty":-6.978437,"marketCap":17885556995},{"date":"2025-01-10","current":-5.450117,"twenty":-12.058756,"median":-9.391379,"eighty":-6.644107,"marketCap":14683190599},{"date":"2025-01-17","current":-5.875315,"twenty":-12.04248,"median":-9.241225,"eighty":-6.25569,"marketCap":15841493338},{"date":"2025-01-24","current":-6.177753,"twenty":-11.949888,"median":-9.172529,"eighty":-6.11967,"marketCap":16761321984},{"date":"2025-01-28","current":-6.498305,"twenty":-11.921589,"median":-9.112153,"eighty":-6.130311,"marketCap":17715218357},{"date":"2025-02-07","current":-7.424154,"twenty":-11.872333,"median":-8.96938,"eighty":-6.148709,"marketCap":20134027017},{"date":"2025-02-14","current":-8.323374,"twenty":-11.760531,"median":-8.922014,"eighty":-6.178085,"marketCap":22518767950},{"date":"2025-02-21","current":-10.607329,"twenty":-11.720414,"median":-8.939394,"eighty":-6.187416,"marketCap":28855365285},{"date":"2025-02-28","current":-8.380735,"twenty":-11.643652,"median":-8.964036,"eighty":-6.222464,"marketCap":22723174315},{"date":"2025-03-07","current":-8.409794,"twenty":-11.556185,"median":-8.912474,"eighty":-6.239893,"marketCap":22893512953},{"date":"2025-03-14","current":-8.131514,"twenty":-11.5122,"median":-8.860603,"eighty":-6.269085,"marketCap":22144022946},{"date":"2025-03-21","current":-7.997044,"twenty":-11.440339,"median":-8.816527,"eighty":-6.340941,"marketCap":21769277942},{"date":"2025-03-28","current":-9.307254,"twenty":-11.391935,"median":-8.776023,"eighty":-6.503525,"marketCap":25284615976},{"date":"2025-04-03","current":-13.220486,"twenty":-11.563082,"median":-8.857032,"eighty":-6.524404,"marketCap":21465794803},{"date":"2025-04-11","current":-11.616184,"twenty":-11.563082,"median":-8.876505,"eighty":-6.613619,"marketCap":18692124688},{"date":"2025-04-17","current":-8.481901,"twenty":-11.535495,"median":-8.876505,"eighty":-6.644107,"marketCap":18290143512},{"date":"2025-04-25","current":-9.200975,"twenty":-11.479403,"median":-8.897671,"eighty":-6.665344,"marketCap":19857870099},{"date":"2025-05-02","current":-9.49742,"twenty":-11.434072,"median":-8.939394,"eighty":-6.691701,"marketCap":20541238098},{"date":"2025-05-09","current":-8.545306,"twenty":-11.391935,"median":-8.912474,"eighty":-6.740034,"marketCap":18611728453},{"date":"2025-05-14","current":-8.240535,"twenty":-11.321925,"median":-8.892407,"eighty":-6.807272,"marketCap":18089152924}],"updateTime":1747303465568}}}